Get started
Author

Karina B Fama

Observed names: K. Fama, Karina Fama
ORCID: 0009-0009-8974-3196
Observed ORCID: 0009-0009-8974-3196
OpenAlex ID: A5114449899
Most Transfers from Urgent Care Centers to Emergency Departments Are Discharged and Many Are Unnecessary
2018 · Tony Zitek, Ignasia Tanone, et al. · Journal of Emergency Medicine · 17
Histology Agnostic Drug Development: An Updated Review
2024 · Kevin Nguyen, Karina Fama, et al. · Cancers · 9
PDF
Efficacy of definitive radiotherapy with concurrent and adjuvant immune checkpoint inhibitors in patients with locally advanced head and neck squamous cell carcinoma (LA HNSCC).
2025 · Hazem Aboaid, Taimur Khalid, et al. · Journal of Clinical Oncology · 2
Abstract B044: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials to Assess Risk of Locoregional Adverse Events in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors
2025 · Rishi K Nanda, Daniel T Jones, et al. · Cancer Immunology Research · 1
Addition of immune checkpoint inhibitor to standard of care chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis
2026 · Ramaditya Srinivasmurthy, Jason Ta, et al. · Exploration of Targeted Anti-tumor Therapy
PDF
HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors
2025 · Taimur Khalid, Hazem Aboaid, et al. · Journal of the National Comprehensive Cancer Network
Abstract B037: Incidence of General Systemic Adverse Events in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials
2025 · Daniel T Jones, Rishi K Nanda, et al. · Cancer Immunology Research
Abstract B039: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Efficacy of the Addition of Immune Checkpoint Inhibitors in Patients with Locally Advanced Nasopharyngeal Carcinoma
2025 · Ramaditya Srinivasmurthy, Taimur Khalid, et al. · Cancer Immunology Research
Abstract B042: Assessing the risk of locoregional, general, hematological, and late adverse events in patients with locally advanced nasopharyngeal carcinoma treated with immune checkpoint inhibitors - a systematic review and meta-analysis
2025 · Taimur Khalid, Ramaditya Srinivasmurthy, et al. · Cancer Immunology Research
Abstract B043: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Assess the Risk of Immune-Related Adverse Effects (irAEs) in Patients with Locally Advanced Nasopharyngeal Carcinoma Treated with Immune Checkpoint Inhibitors
2025 · Ramaditya Srinivasmurthy, Rishi K Nanda, et al. · Cancer Immunology Research
232 Urgent Care Transfers to the Emergency Department Are Often Unnecessary
2017 · T. Zitek, K. Fama, et al. · Annals of Emergency Medicine
Works count: 11
Citation count: 29
H-index: 2
I10-index: 1
Year
Topic
Type